The results from Kaplan–Meier analysis showed that higher expression of CHTOP was associated with a significantly lower 10-year DFS rate in ovarian cancer patients (P<0.001) (Figure 1A). The gene discussed is CHTOP; the disease is ovarian carcinoma.